# Dave Inc.: filings

DAVE · Nasdaq · CIK 1841408 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dave.md) · [Financials](/companies/dave/financials.md) · [Filings](/companies/dave/filings.md) · [Insiders](/companies/dave/insiders.md)

## Reports and events: 111 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 121, 8-K 64, 144 30, 425 23, 424B3 21, 3 19, 10-Q 17, CORRESP 15, UPLOAD 10, SCHEDULE 13G/A 8, SC 13D/A 7, SCHEDULE 13G 7, DEF 14A 6, 10-K 5, DEFA14A 5, EFFECT 5, POS AM 5, S-8 5, SC 13G 5, ARS 4, S-4/A 4, SC 13G/A 4, SCHEDULE 13D/A 3, 10-Q/A 2, 4/A 2, 8-A12B 2, 8-K/A 2, CERT 2, NT 10-Q 2, PRE 14A 2, S-1 2, SC 13D 2, 25 1, 424B4 1, DEL AM 1, DRS 1, S-1/A 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-15 | 17:00 ET | [SCHEDULE 13D/A](/filings/0001193125-26-392095.md) | Ownership report, active investor, amended | 0001193125-26-392095 |
| 2026-08-14 | 16:30 ET | [8-K](/filings/0001193125-26-352390.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-352390 |
| 2026-08-05 | 16:16 ET | [10-Q](/filings/0001193125-26-335154.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335154 |
| 2026-08-05 | 16:11 ET | [8-K](/filings/0001193125-26-335119.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335119 |
| 2026-06-02 | 17:00 ET | [8-K](/filings/0001193125-26-253774.md) | 5.07 Shareholder vote results | 0001193125-26-253774 |
| 2026-05-05 | 16:16 ET | [8-K](/filings/0001193125-26-206471.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206471 |
| 2026-05-05 | 16:15 ET | [10-Q](/filings/0001193125-26-206446.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206446 |
| 2026-04-20 | 17:00 ET | [DEF 14A](/filings/0001193125-26-164199.md) | Proxy statement, period 2026-04-20 | 0001193125-26-164199 |
| 2026-03-09 | 17:10 ET | [8-K](/filings/0001193125-26-098802.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-098802 |
| 2026-03-06 | 19:24 ET | [8-K](/filings/0001193125-26-094530.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-094530 |
| 2026-03-03 | 16:38 ET | [8-K](/filings/0001193125-26-088439.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-088439 |
| 2026-03-02 | 16:12 ET | [8-K](/filings/0001841408-26-000003.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001841408-26-000003 |
| 2026-03-02 | 16:06 ET | [10-K](/filings/0001193125-26-085370.md) | Annual report, period 2025-12-31 | 0001193125-26-085370 |
| 2026-02-05 | 16:19 ET | [8-K](/filings/0001193125-26-039438.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-039438 |
| 2026-01-21 | 18:13 ET | [8-K](/filings/0001193125-26-016910.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-016910 |
| 2025-11-04 | 16:31 ET | [10-Q](/filings/0001193125-25-264819.md) | Quarterly report, period 2025-09-30 | 0001193125-25-264819 |
| 2025-11-04 | 07:06 ET | [8-K](/filings/0001193125-25-263535.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263535 |
| 2025-08-13 | 08:04 ET | [8-K](/filings/0001193125-25-179459.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-179459 |
| 2025-08-06 | 16:00 ET | [10-Q](/filings/0000950170-25-103967.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103967 |
| 2025-08-06 | 08:00 ET | [8-K](/filings/0001193125-25-174014.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-174014 |
| 2025-07-15 | 19:07 ET | [8-K](/filings/0001193125-25-158858.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-158858 |
| 2025-06-17 | 17:25 ET | [SCHEDULE 13D/A](/filings/0000950170-25-087513.md) | Ownership report, active investor, amended | 0000950170-25-087513 |
| 2025-06-03 | 16:30 ET | [8-K](/filings/0001193125-25-134152.md) | 5.07 Shareholder vote results | 0001193125-25-134152 |
| 2025-05-08 | 16:30 ET | [10-Q](/filings/0000950170-25-067073.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067073 |
| 2025-05-08 | 07:15 ET | [8-K](/filings/0001193125-25-115471.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-115471 |
| 2025-04-18 | 16:30 ET | [DEF 14A](/filings/0001140361-25-014576.md) | Proxy statement, period 2025-06-02 | 0001140361-25-014576 |
| 2025-03-17 | 19:25 ET | [SCHEDULE 13D/A](/filings/0000950170-25-040612.md) | Ownership report, active investor, amended | 0000950170-25-040612 |
| 2025-03-10 | 08:47 ET | [8-K](/filings/0001193125-25-050438.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-050438 |
| 2025-03-04 | 16:30 ET | [10-K](/filings/0000950170-25-032164.md) | Annual report, period 2024-12-31 | 0000950170-25-032164 |
| 2025-03-03 | 16:10 ET | [8-K](/filings/0001193125-25-044114.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-044114 |
| 2025-03-03 | 08:00 ET | [8-K](/filings/0001193125-25-043439.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-043439 |
| 2025-02-20 | 09:01 ET | [8-K](/filings/0001193125-25-030195.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-030195 |
| 2024-12-31 | 06:08 ET | [8-K](/filings/0001193125-24-287056.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-287056 |
| 2024-11-12 | 16:30 ET | [10-Q](/filings/0000950170-24-125522.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125522 |
| 2024-11-12 | 16:11 ET | [8-K](/filings/0001193125-24-255957.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-255957 |
| 2024-11-12 | 09:01 ET | [8-K](/filings/0001193125-24-255242.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-255242 |
| 2024-11-05 | 17:22 ET | [8-K](/filings/0001193125-24-251349.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-251349 |
| 2024-10-18 | 17:01 ET | [SC 13D/A](/filings/0001104659-24-109895.md) | Ownership report, active investor, amended | 0001104659-24-109895 |
| 2024-10-11 | 18:00 ET | [SC 13D/A](/filings/0001104659-24-108132.md) | Ownership report, active investor, amended | 0001104659-24-108132 |
| 2024-08-06 | 16:30 ET | [10-Q](/filings/0000950170-24-091896.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091896 |
| 2024-08-06 | 06:06 ET | [8-K](/filings/0001193125-24-194330.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-194330 |
| 2024-06-04 | 16:31 ET | [8-K](/filings/0001193125-24-154304.md) | 5.07 Shareholder vote results | 0001193125-24-154304 |
| 2024-05-14 | 17:57 ET | [SC 13D/A](/filings/0001104659-24-061267.md) | Ownership report, active investor, amended | 0001104659-24-061267 |
| 2024-05-09 | 17:22 ET | [SC 13D/A](/filings/0001104659-24-059456.md) | Ownership report, active investor, amended | 0001104659-24-059456 |
| 2024-05-07 | 16:30 ET | [10-Q](/filings/0000950170-24-054605.md) | Quarterly report, period 2024-03-31 | 0000950170-24-054605 |
| 2024-05-07 | 07:31 ET | [8-K](/filings/0001193125-24-132578.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-132578 |
| 2024-04-22 | 16:30 ET | [DEF 14A](/filings/0001140361-24-021029.md) | Proxy statement, period 2024-06-03 | 0001140361-24-021029 |
| 2024-03-05 | 16:30 ET | [10-K](/filings/0000950170-24-026024.md) | Annual report, period 2023-12-31 | 0000950170-24-026024 |
| 2024-03-05 | 08:00 ET | [8-K](/filings/0001193125-24-058700.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-058700 |
| 2024-01-05 | 09:01 ET | [8-K](/filings/0001193125-24-002933.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-002933 |

Page 1 of 3. [Older](/companies/dave/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.